A randomized controlled study to compare the effects of angiotensin II type 1 receptor blockers (telmisartan vs candesartan vs valsartan) on the markers of cardiovascular risk in hypertensive patients with type 2 diabetes mellitus
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 07 Aug 2009
At a glance
- Drugs Candesartan cilexetil (Primary) ; Telmisartan (Primary) ; Valsartan (Primary)
- Indications Hypertension
- Focus Biomarker; Pharmacodynamics
- 07 Aug 2009 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 09 Feb 2009 Status changed from not stated to recruiting.
- 09 Feb 2009 New trial record.